Laevoroc
Biotechnology Research
Hünenberg, Zug, Ch
4 employees
- Employees
- 4
- Contacts
- 2
- Emails
- 2
- Phones
- 1
Laevoroc Overview
- Headquarters
- Hünenberg, Zug, Ch
- Website
- www.laevoroc.com
- Industry
- Biotechnology Research
- Employees
- 4
- Founded
- 2019
- Funding
- 1.1M
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
About Laevoroc
Spearheading the development of a novel PNP inhibitor poised to revolutionize treatment for leukaemia patients facing relapse post-stem cell transplantation.
Laevoroc Contact Details
- People in AeroLeads
- 3
- With contact data
- 2
- Email contacts
- 2
- 66.7% coverage
- Phone contacts
- 1
- 33.3% coverage
Laevoroc Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Thomas Mehrling | Riehen, Basel, Switzerland |
Email
|
|
| Shanta Bantia | Co-founder-cso at Laevoroc Immunology | Greater Birmingham, Alabama Area, United States |
Email
Phone
|
| Dr. Athanasios Zikopoulos | CEO at Lipomed Ag | Arlesheim, Basel-country, Switzerland |
View
|
Compare Similar Companies to Laevoroc
Mundipharma
Pharmaceutical Manufacturing
Nouscom
Biotechnology Research
Helix Biopharma Corp.
Biotechnology Research
NXI Therapeutics AG
Biotechnology Research
metaShape Pharma
Biotechnology Research
Samjin Pharmaceutical Co Ltd
Multi-signal peer
Allegria Therapeutics
Biotechnology Research
APITBIO Inc.
Related company record
Pulmokine, Inc.
Pharmaceutical Manufacturing
SynDermix AG
Biotechnology